Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

LAKE FOREST, Ill., May 1, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2012. Net sales for the quarter were $966 million and adjusted* diluted earnings per share were $0.47. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)

"Hospira delivered first-quarter results in line with our expectations, which reflects a difficult year-over-year comparison and the impact of our quality improvement initiatives," said F. Michael Ball, chief executive officer. "Going forward, we remain firmly focused on advancing our remediation efforts and, at the same time, expanding our global footprint and capacity to capitalize on our growth opportunities. We believe these initiatives will position Hospira with an even stronger competitive advantage, creating sustainable, long-term shareholder value."

First-Quarter 2012 ResultsThe following table highlights selected financial results for the first quarter of 2012 compared to the same period in 2011:In $ millions,

except per share

amounts

GAAP

Three Months Ended

March 31, Adjusted*

Three Months Ended

March 31,2012

2011

%

Change

2012

2011

%

ChangeNet Sales

$965.9

$1,002.3

(3.6)%

n/a

n/a

n/aGross Profit (Net Sales less

Cost of Products Sold)

$300.0

$399.1

(24.8)%

$357.5

$424.3

(15.7)%Income from Operations

$46.7

$163.8

(71.5)%

$104.2

$203.4

(48.8)%Diluted Earnings per Share

$0.24

$0.88

(72.7)%

$0.47

$0.93

(49.5)%Statistics (as a % of Net
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 Sargas Pharmaceutical ... (CCM) and Drug Adherence m Health applications along ... the process of non face-to-face monitoring of twenty ... new release of our apps, doctors are now ... along with our ONCHIT certified Physician, Pharmacy and ...
(Date:9/1/2015)... California , September 1, 2015 ... is segmented on the basis of sectors, products ... chronic diseases globally coupled with the increasing demand ... diseases are expected to propel the growth for ... manage biological information efficiently is known as bioinformatics. ...
(Date:9/1/2015)... -- In nur zwei Jahren nach dem Erreichen ... Group schnell weltweit 3.000 Mitarbeiter erreicht. Diese Steigerung ... Markt der injizierbaren Medikamente und das ... SHL wieder. Foto - http://photos.prnewswire.com/prnh/20150820/259886 ... Design und Herstellung automatischer Injektoren und Pen-Injektoren und ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... 18, 2011 Par Pharmaceutical Companies, Inc. (NYSE: ... to three products from Teva Pharmaceuticals in connection with ... Par will own the ANDAs of fentanyl citrate lozenges, ... the generic version of Amrix®, as well as the ...
... announced today the launch of its Gifts & ... no cost.  The TRACE software solution addresses a ... (FCPA) enforcement actions against corporations and individuals for ... gifts, hospitality and travel.   Prosecutors ...
Cached Medicine Technology:Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals 2TRACE Launches Leading Edge Anti-Bribery Compliance Software 2TRACE Launches Leading Edge Anti-Bribery Compliance Software 3
(Date:9/2/2015)... ... September 02, 2015 , ... Available in select spas ... PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution of the classic ... with a lipid-replenishing marine oil for intense nourishing and moisturizing. Phytomer exclusive ingredient ...
(Date:9/2/2015)... ... 02, 2015 , ... Canopy Partners, a North Carolina based ... 5000 List, an independent ranking of the fastest- growing private companies in ... achievement puts Canopy in rarefied company. Over the years, this elite group has ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an ... flora and fauna. , Lifestyle Holidays Vacation Club knows that Puerto ... travelers experience that much better, Lifestyle Holidays Vacation Club has put together its list ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... September is ... this disease that affects more than 233,000 men each year in the United States. ... the most common non-skin cancer in America, affecting 1 in 7 men. One new ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
Breaking Medicine News(10 mins):Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3
... 12, 2011Michael L. Dennis, Ph.D., Senior Research Psychologist ... Christy K. Scott, Ph.D., Research Psychologist at the ... Anderson Research Award for their long-term outcomes study ... treatment outcomes among adults attending alcohol/drug treatment. Sponsored ...
... Public Images: Cut and paste into the body of ... search to date of DNA abnormalities in chronic lymphocytic ... drive this common blood cancer, a finding that could ... will progress rapidly or remain indolent for years, say ...
... Medical researchers at the University of Alberta have created ... and informational topics related to weight, that parents can ... child,s weight management with health professionals. Researchers in ... of Alberta created these ,conversation cards, based on their ...
... multiforme (GBM) is the most common and lethal of ... For most patients, treatment involves surgery followed by both ... are resistant to the effects of temozolomide. A team ... of Toronto, Toronto, has now determined that the protein ...
... brain atrophy patterns in Alzheimer,s disease patients using MRIs ... to a new study by researchers from the Perelman ... also found that higher baseline Alzheimer,s patterns of atrophy ... The study is published online in Brain . ...
... be part of the Homo erectus diet. But the ... survival of Homo erectus and the evolution of modern ... Tel Aviv University researchers Dr. Ran Barkai, Miki Ben-Dor, and Prof. ... Studies examined the published data describing animal bones associated with ...
Cached Medicine News:Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 2Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 3Health News:Massive DNA search uncovers new mutations driving blood cancer 2Health News:Massive DNA search uncovers new mutations driving blood cancer 3Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 2Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 3Health News:Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease 2Health News:The disappearance of the elephant caused the rise of modern man 2Health News:The disappearance of the elephant caused the rise of modern man 3
... to dilate the lower ureter ... assess possible submucosal tunneling. Also ... anesthetic in the ureter. The ... or dislodgment of a ureteral ...
... Used for the injection of contrast medium, ... dual lumen design eliminates the need for ... to promote atraumatic passage into and through ... of hydrophilic polymer that when activated, attracts ...
Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Medicine Products: